The LDN–Cell Danger Response Convergence Hypothesis: Could Low-Dose Naltrexone Indirectly Modulate Purinergic Signaling in Chronic Subclinical Inflammation and HPG-Axis Suppression? — A Hypothesis
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician What this article is — and is not. This is a hypothesis. It proposes a biologically plausible, testable model in which low-dose naltrexone (LDN) might indirectly influence purinergic “cell danger” signaling and, in turn, inflammation-